Publication:
Inducible nitric oxide synthase activation by interleukin-17

dc.contributor.authorMiljkovic, Djordje (7006524033)
dc.contributor.authorTrajkovic, Vladimir (7004516866)
dc.date.accessioned2025-06-13T00:40:18Z
dc.date.available2025-06-13T00:40:18Z
dc.date.issued2004
dc.description.abstractInterleukin-17 (IL-17) is a proinflammatory T cell cytokine presumably involved in physiological responses to infection, but also in immunopathology of autoimmune disorders such as rheumatoid arthritis. The proinflammatory action of IL-17 depends considerably on its ability to trigger the expression of inducible nitric oxide (NO) synthase (iNOS), an enzyme responsible for the generation of cytotoxic and immunoregulatory free radical NO. Here we discuss the role of IL-17 in the cytokine network controlling iNOS expression, and analyze signaling pathways employed by IL-17 for the initiation of iNOS gene transcription. We also propose biological consequences of IL-17-mediated NO release that could be relevant for the mechanisms or therapy of autoimmune and inflammatory disorders. © 2003 Elsevier Ltd. All rights reserved.
dc.identifier.urihttps://doi.org/10.1016/j.cytogfr.2003.10.003
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-1642554789&doi=10.1016%2fj.cytogfr.2003.10.003&partnerID=40&md5=83073f1fb27653c66157b06cb82c0658
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/11186
dc.subjectAutoimmunity
dc.subjectIL-17
dc.subjectiNOS
dc.subjectNitric oxide
dc.titleInducible nitric oxide synthase activation by interleukin-17
dspace.entity.typePublication

Files